Ontology type: schema:ScholarlyArticle Open Access: True
2020-07-03
AUTHORSAtsushi Kawaguchi, Gabrielle Bernier, Jacques Lacroix, Saly El Salti, Matthew P. Cheng, Todd C. Lee, Kosar Khwaja, Philippe Jouvet
ABSTRACTObjectivesAs there is no treatment for COVID-19 with a proven mortality benefit at this moment in the pandemic, supportive management including mechanical ventilation is the core management in an intensive care unit (ICU). It is a challenge to provide consistent care in this situation, highly demanding and leading to potential staff shortages in ICU. We need to reduce unnecessary exposure of healthcare workers to the virus. This study aims to examine the impact of care using a non-invasive oscillating device (NIOD) for chest physiotherapy in the care of mechanically ventilated patients with COVID-19. In particular, we aim to explore if a NIOD performed by non-specialized personnel is not inferior to the standard chest physiotherapy (CPT) undertaken by physiotherapists caring for patients with COVID-19.Trial designA pilot multicenter prospective crossover noninferiority randomized controlled trial.ParticipantsAll mechanically ventilated patients with COVID-19 admitted to one of the two ICUs, and CPT ordered by the responsible physician. The participants will be recruited from two intensive care units in Canadian Academic Hospitals (one pediatric and one adult ICU).Intervention and comparatorWe will implement NIOD and CPT alternatingly for 3 h apart over 3 h. We will apply a pragmatic design, so that other procedures including hypertonic saline nebulization, intermittent positive pressure ventilation, suctioning (e.g., oral or nasal), or changing the ventilator settings or modality (i.e., increasing positive end-expiratory pressure or changing the nasal mask to total face continuous positive airway pressure) can be provided at the direction of bedside intensivists in charge.Main outcomesThe primary outcome measurement is the oxygenation level before and after the procedure (SpO2/FiO2 ratio). For cases with invasive ventilation (i.e., the use of an endotracheal tube to deliver positive pressure) and non-invasive ventilation, we will also document expiratory tidal volume, vital signs, and any related complications such as vomiting, hypoxemia, or unexpected extubation. We will collect the data before, 10 min after, and 30 min after the procedure.RandomizationThe order of the procedures (i.e., NIOD or CPT) will be randomly allocated using manual generated random numbers for each case. Randomization will be carried out by the independent research assistant in the study coordinating center by using opaque sealed envelopes, assigning an equal number of cases to each intervention arm. Stratification will be applied for age (> 18 years or ≤ 18 years of age) and the study sites.Blinding (masking)No blinding will be performed.Numbers to be randomized (sample size)We estimate the necessary sample size as 25 for each arm (total 50 cases), with a power of 0.90 and an alpha of 0.05, with a non-inferiority design.Trial statusThe protocol version number 1 was approved on 27 March 2020. Currently, recruitment has not yet started, with the start scheduled by the mid-June 2020 and the end anticipated by December 2020.Trial registrationClinicalTrials.gov NCT04361435. Registered on 28 April 2020Full protocolThe full protocol is attached as an additional file, accessible from the Trials website (Additional File 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this letter serves as a summary of the key elements of the full protocol. More... »
PAGES610
http://scigraph.springernature.com/pub.10.1186/s13063-020-04533-6
DOIhttp://dx.doi.org/10.1186/s13063-020-04533-6
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1128973322
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/32620174
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Betacoronavirus",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "COVID-19",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Coronavirus Infections",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Critical Illness",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Equivalence Trials as Topic",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Host-Pathogen Interactions",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Lung",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Multicenter Studies as Topic",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Pandemics",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Physical Therapy Modalities",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Pilot Projects",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Pneumonia, Viral",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Quebec",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Respiration, Artificial",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "SARS-CoV-2",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Time Factors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Pediatrics, Children\u2019s Hospital Eastern Ontario, University of Ottawa, Ottawa, Canada",
"id": "http://www.grid.ac/institutes/grid.414148.c",
"name": [
"Department of Pediatrics, University of Montreal, CHU Sainte-Justine, 3175 Chemin de C\u00f4te Sainte Catherine, H3T 1C5, Quebec, QB, Canada",
"Department of Pediatrics, Children\u2019s Hospital Eastern Ontario, University of Ottawa, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Kawaguchi",
"givenName": "Atsushi",
"id": "sg:person.0736602315.48",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736602315.48"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "School of Medicine, University of Montreal, Quebec, Canada",
"id": "http://www.grid.ac/institutes/grid.14848.31",
"name": [
"School of Medicine, University of Montreal, Quebec, Canada"
],
"type": "Organization"
},
"familyName": "Bernier",
"givenName": "Gabrielle",
"id": "sg:person.010332126163.53",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010332126163.53"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatrics, University of Montreal, CHU Sainte-Justine, 3175 Chemin de C\u00f4te Sainte Catherine, H3T 1C5, Quebec, QB, Canada",
"id": "http://www.grid.ac/institutes/grid.14848.31",
"name": [
"Department of Pediatrics, University of Montreal, CHU Sainte-Justine, 3175 Chemin de C\u00f4te Sainte Catherine, H3T 1C5, Quebec, QB, Canada"
],
"type": "Organization"
},
"familyName": "Lacroix",
"givenName": "Jacques",
"id": "sg:person.0701307445.10",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701307445.10"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatrics, University of Montreal, CHU Sainte-Justine, 3175 Chemin de C\u00f4te Sainte Catherine, H3T 1C5, Quebec, QB, Canada",
"id": "http://www.grid.ac/institutes/grid.14848.31",
"name": [
"Department of Pediatrics, University of Montreal, CHU Sainte-Justine, 3175 Chemin de C\u00f4te Sainte Catherine, H3T 1C5, Quebec, QB, Canada"
],
"type": "Organization"
},
"familyName": "El Salti",
"givenName": "Saly",
"type": "Person"
},
{
"affiliation": {
"alternateName": "McGill Interdisciplinary Initiative in Infection and Immunity, Quebec, Canada",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Divisions of Infectious Diseases and Medical Microbiology, McGill University Health Centre, Quebec, Canada",
"McGill Interdisciplinary Initiative in Infection and Immunity, Quebec, Canada"
],
"type": "Organization"
},
"familyName": "Cheng",
"givenName": "Matthew P.",
"id": "sg:person.0763066411.12",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763066411.12"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Quebec, Canada",
"id": "http://www.grid.ac/institutes/grid.63984.30",
"name": [
"McGill Interdisciplinary Initiative in Infection and Immunity, Quebec, Canada",
"Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Quebec, Canada"
],
"type": "Organization"
},
"familyName": "Lee",
"givenName": "Todd C.",
"id": "sg:person.01357623642.21",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357623642.21"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "R\u00e9seau de Recherche en Sant\u00e9 Respiratoire du Qu\u00e9bec, Quebec, Canada",
"id": "http://www.grid.ac/institutes/None",
"name": [
"R\u00e9seau de Recherche en Sant\u00e9 Respiratoire du Qu\u00e9bec, Quebec, Canada"
],
"type": "Organization"
},
"familyName": "Khwaja",
"givenName": "Kosar",
"id": "sg:person.01051400466.56",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051400466.56"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatrics, University of Montreal, CHU Sainte-Justine, 3175 Chemin de C\u00f4te Sainte Catherine, H3T 1C5, Quebec, QB, Canada",
"id": "http://www.grid.ac/institutes/grid.14848.31",
"name": [
"Department of Pediatrics, University of Montreal, CHU Sainte-Justine, 3175 Chemin de C\u00f4te Sainte Catherine, H3T 1C5, Quebec, QB, Canada"
],
"type": "Organization"
},
"familyName": "Jouvet",
"givenName": "Philippe",
"id": "sg:person.01254157220.25",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254157220.25"
],
"type": "Person"
}
],
"datePublished": "2020-07-03",
"datePublishedReg": "2020-07-03",
"description": "ObjectivesAs there is no treatment for COVID-19 with a proven mortality benefit at this moment in the pandemic, supportive management including mechanical ventilation is the core management in an intensive care unit (ICU). It is a challenge to provide consistent care in this situation, highly demanding and leading to potential staff shortages in ICU. We need to reduce unnecessary exposure of healthcare workers to the virus. This study aims to examine the impact of care using a non-invasive oscillating device (NIOD) for chest physiotherapy in the care of mechanically ventilated patients with COVID-19. In particular, we aim to explore if a NIOD performed by non-specialized personnel is not inferior to the standard chest physiotherapy (CPT) undertaken by physiotherapists caring for patients with COVID-19.Trial designA pilot multicenter prospective crossover noninferiority randomized controlled trial.ParticipantsAll mechanically ventilated patients with COVID-19 admitted to one of the two ICUs, and CPT ordered by the responsible physician. The participants will be recruited from two intensive care units in Canadian Academic Hospitals (one pediatric and one adult ICU).Intervention and comparatorWe will implement NIOD and CPT alternatingly for 3\u2009h apart over 3\u2009h. We will apply a pragmatic design, so that other procedures including hypertonic saline nebulization, intermittent positive pressure ventilation, suctioning (e.g., oral or nasal), or changing the ventilator settings or modality (i.e., increasing positive end-expiratory pressure or changing the nasal mask to total face continuous positive airway pressure) can be provided at the direction of bedside intensivists in charge.Main outcomesThe primary outcome measurement is the oxygenation level before and after the procedure (SpO2/FiO2 ratio). For cases with invasive ventilation (i.e., the use of an endotracheal tube to deliver positive pressure) and non-invasive ventilation, we will also document expiratory tidal volume, vital signs, and any related complications such as vomiting, hypoxemia, or unexpected extubation. We will collect the data before, 10\u2009min after, and 30\u2009min after the procedure.RandomizationThe order of the procedures (i.e., NIOD or CPT) will be randomly allocated using manual generated random numbers for each case. Randomization will be carried out by the independent research assistant in the study coordinating center by using opaque sealed envelopes, assigning an equal number of cases to each intervention arm. Stratification will be applied for age (>\u200918\u2009years or\u2009\u2264\u200918\u2009years of age) and the study sites.Blinding (masking)No blinding will be performed.Numbers to be randomized (sample size)We estimate the necessary sample size as 25 for each arm (total 50 cases), with a power of 0.90 and an alpha of 0.05, with a non-inferiority design.Trial statusThe protocol version number 1 was approved on 27 March 2020. Currently, recruitment has not yet started, with the start scheduled by the mid-June 2020 and the end anticipated by December 2020.Trial registrationClinicalTrials.gov NCT04361435. Registered on 28 April 2020Full protocolThe full protocol is attached as an additional file, accessible from the Trials website (Additional File 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this letter serves as a summary of the key elements of the full protocol.",
"genre": "article",
"id": "sg:pub.10.1186/s13063-020-04533-6",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1297400",
"issn": [
"1468-6708",
"1745-6215"
],
"name": "Trials",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "21"
}
],
"keywords": [
"intensive care unit",
"chest physiotherapy",
"care unit",
"intermittent positive pressure ventilation",
"COVID-19",
"standard chest physiotherapy",
"non-invasive ventilation",
"positive pressure ventilation",
"primary outcome measurement",
"hypertonic saline nebulization",
"COVID-19 infection",
"non-inferiority design",
"expiratory tidal volume",
"independent research assistant",
"impact of care",
"Canadian academic hospital",
"potential staff shortages",
"full protocol",
"invasive ventilation",
"mortality benefit",
"related complications",
"mechanical ventilation",
"pressure ventilation",
"intervention arm",
"Trials website",
"ventilator settings",
"supportive management",
"ill children",
"study protocol",
"responsible physician",
"saline nebulization",
"healthcare workers",
"academic hospital",
"consistent care",
"tidal volume",
"outcome measurements",
"unnecessary exposure",
"vital signs",
"unexpected extubation",
"patients",
"pragmatic design",
"ventilation",
"oxygenation level",
"care",
"staff shortages",
"physiotherapy",
"research assistants",
"trials",
"equal number",
"structured summary",
"sample size",
"extubation",
"vomiting",
"hypoxemia",
"intensivists",
"complications",
"noninferiority",
"airway",
"hospital",
"arm",
"blinding",
"infection",
"min",
"physiotherapists",
"physicians",
"cases",
"protocol",
"intervention",
"age",
"adults",
"management",
"virus",
"procedure",
"treatment",
"modalities",
"children",
"randomization",
"necessary sample size",
"alpha",
"summary",
"study",
"signs",
"exposure",
"nebulization",
"participants",
"stratification",
"setting",
"oscillating device",
"recruitment",
"dissemination",
"number",
"levels",
"center",
"workers",
"personnel",
"start",
"units",
"benefits",
"manual",
"assistants",
"pilot",
"volume",
"non-specialized personnel",
"samples",
"key elements",
"data",
"sites",
"study sites",
"impact",
"end",
"comparison",
"number 1",
"shortage",
"challenges",
"files",
"core management",
"websites",
"additional files",
"size",
"design",
"method",
"measurements",
"situation",
"interest",
"envelope",
"materials",
"random numbers",
"order",
"devices",
"formatting",
"direction",
"letter",
"elements",
"moment",
"charge",
"power"
],
"name": "Comparison of two methods to clear the airways of critically ill children and adults with COVID-19 infection: a structured summary of a study protocol for a pilot randomized controlled trial",
"pagination": "610",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1128973322"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/s13063-020-04533-6"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"32620174"
]
}
],
"sameAs": [
"https://doi.org/10.1186/s13063-020-04533-6",
"https://app.dimensions.ai/details/publication/pub.1128973322"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-20T07:37",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_855.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1186/s13063-020-04533-6"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13063-020-04533-6'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13063-020-04533-6'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13063-020-04533-6'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13063-020-04533-6'
This table displays all metadata directly associated to this object as RDF triples.
338 TRIPLES
21 PREDICATES
181 URIs
173 LITERALS
26 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1186/s13063-020-04533-6 | schema:about | N0dacabd4753841109f5269e05d8bddb3 |
2 | ″ | ″ | N0f59291a2e2e43058f0be6462f9453bd |
3 | ″ | ″ | N1a783f2138a0441c9cd6ce95b5bef71f |
4 | ″ | ″ | N1e48c0212a754598b9da8c3a48591052 |
5 | ″ | ″ | N25669df7f7f24a1fb369f23bb2ffe916 |
6 | ″ | ″ | N296db1fe4f844448a6706dcbec77b657 |
7 | ″ | ″ | N2a035d0edf5c47f4b4ceecdab2110af8 |
8 | ″ | ″ | N3b0fe888751c4ef3a2ef207eef389003 |
9 | ″ | ″ | N48c17be93ea04bcab97e2d12a7f24e4b |
10 | ″ | ″ | N5864f4d51276498f891988ca353457ba |
11 | ″ | ″ | N644a191afa434ccfbac6926ef4f7c1c7 |
12 | ″ | ″ | N69d2d850293840cbabd39ca452f4e254 |
13 | ″ | ″ | N74889e30e96d42cab7a33e8e1a079498 |
14 | ″ | ″ | N80bbe4655b474abd8a77d70e43e9ae5c |
15 | ″ | ″ | N99879bd0190546c092577b89858a4298 |
16 | ″ | ″ | N9c9fef50df9f4fe0a5a2431f5ae23032 |
17 | ″ | ″ | Na0c1fdf5ff0b4c7eadf357a7dea580ec |
18 | ″ | ″ | Nd6b92a98f6af43ab8c4f5c1e685080e5 |
19 | ″ | ″ | Neb6062775ddd4db4aba246b63c77244b |
20 | ″ | ″ | anzsrc-for:11 |
21 | ″ | ″ | anzsrc-for:1103 |
22 | ″ | schema:author | Nc0fe7d8bf52f4ee4b2d9066b4d849109 |
23 | ″ | schema:datePublished | 2020-07-03 |
24 | ″ | schema:datePublishedReg | 2020-07-03 |
25 | ″ | schema:description | ObjectivesAs there is no treatment for COVID-19 with a proven mortality benefit at this moment in the pandemic, supportive management including mechanical ventilation is the core management in an intensive care unit (ICU). It is a challenge to provide consistent care in this situation, highly demanding and leading to potential staff shortages in ICU. We need to reduce unnecessary exposure of healthcare workers to the virus. This study aims to examine the impact of care using a non-invasive oscillating device (NIOD) for chest physiotherapy in the care of mechanically ventilated patients with COVID-19. In particular, we aim to explore if a NIOD performed by non-specialized personnel is not inferior to the standard chest physiotherapy (CPT) undertaken by physiotherapists caring for patients with COVID-19.Trial designA pilot multicenter prospective crossover noninferiority randomized controlled trial.ParticipantsAll mechanically ventilated patients with COVID-19 admitted to one of the two ICUs, and CPT ordered by the responsible physician. The participants will be recruited from two intensive care units in Canadian Academic Hospitals (one pediatric and one adult ICU).Intervention and comparatorWe will implement NIOD and CPT alternatingly for 3 h apart over 3 h. We will apply a pragmatic design, so that other procedures including hypertonic saline nebulization, intermittent positive pressure ventilation, suctioning (e.g., oral or nasal), or changing the ventilator settings or modality (i.e., increasing positive end-expiratory pressure or changing the nasal mask to total face continuous positive airway pressure) can be provided at the direction of bedside intensivists in charge.Main outcomesThe primary outcome measurement is the oxygenation level before and after the procedure (SpO2/FiO2 ratio). For cases with invasive ventilation (i.e., the use of an endotracheal tube to deliver positive pressure) and non-invasive ventilation, we will also document expiratory tidal volume, vital signs, and any related complications such as vomiting, hypoxemia, or unexpected extubation. We will collect the data before, 10 min after, and 30 min after the procedure.RandomizationThe order of the procedures (i.e., NIOD or CPT) will be randomly allocated using manual generated random numbers for each case. Randomization will be carried out by the independent research assistant in the study coordinating center by using opaque sealed envelopes, assigning an equal number of cases to each intervention arm. Stratification will be applied for age (> 18 years or ≤ 18 years of age) and the study sites.Blinding (masking)No blinding will be performed.Numbers to be randomized (sample size)We estimate the necessary sample size as 25 for each arm (total 50 cases), with a power of 0.90 and an alpha of 0.05, with a non-inferiority design.Trial statusThe protocol version number 1 was approved on 27 March 2020. Currently, recruitment has not yet started, with the start scheduled by the mid-June 2020 and the end anticipated by December 2020.Trial registrationClinicalTrials.gov NCT04361435. Registered on 28 April 2020Full protocolThe full protocol is attached as an additional file, accessible from the Trials website (Additional File 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this letter serves as a summary of the key elements of the full protocol. |
26 | ″ | schema:genre | article |
27 | ″ | schema:inLanguage | en |
28 | ″ | schema:isAccessibleForFree | true |
29 | ″ | schema:isPartOf | N86d42ebd23b441f1a96ec4ff90919f4d |
30 | ″ | ″ | Ne3d9e258e0754cddac2fec7a1da174f4 |
31 | ″ | ″ | sg:journal.1297400 |
32 | ″ | schema:keywords | COVID-19 |
33 | ″ | ″ | COVID-19 infection |
34 | ″ | ″ | Canadian academic hospital |
35 | ″ | ″ | Trials website |
36 | ″ | ″ | academic hospital |
37 | ″ | ″ | additional files |
38 | ″ | ″ | adults |
39 | ″ | ″ | age |
40 | ″ | ″ | airway |
41 | ″ | ″ | alpha |
42 | ″ | ″ | arm |
43 | ″ | ″ | assistants |
44 | ″ | ″ | benefits |
45 | ″ | ″ | blinding |
46 | ″ | ″ | care |
47 | ″ | ″ | care unit |
48 | ″ | ″ | cases |
49 | ″ | ″ | center |
50 | ″ | ″ | challenges |
51 | ″ | ″ | charge |
52 | ″ | ″ | chest physiotherapy |
53 | ″ | ″ | children |
54 | ″ | ″ | comparison |
55 | ″ | ″ | complications |
56 | ″ | ″ | consistent care |
57 | ″ | ″ | core management |
58 | ″ | ″ | data |
59 | ″ | ″ | design |
60 | ″ | ″ | devices |
61 | ″ | ″ | direction |
62 | ″ | ″ | dissemination |
63 | ″ | ″ | elements |
64 | ″ | ″ | end |
65 | ″ | ″ | envelope |
66 | ″ | ″ | equal number |
67 | ″ | ″ | expiratory tidal volume |
68 | ″ | ″ | exposure |
69 | ″ | ″ | extubation |
70 | ″ | ″ | files |
71 | ″ | ″ | formatting |
72 | ″ | ″ | full protocol |
73 | ″ | ″ | healthcare workers |
74 | ″ | ″ | hospital |
75 | ″ | ″ | hypertonic saline nebulization |
76 | ″ | ″ | hypoxemia |
77 | ″ | ″ | ill children |
78 | ″ | ″ | impact |
79 | ″ | ″ | impact of care |
80 | ″ | ″ | independent research assistant |
81 | ″ | ″ | infection |
82 | ″ | ″ | intensive care unit |
83 | ″ | ″ | intensivists |
84 | ″ | ″ | interest |
85 | ″ | ″ | intermittent positive pressure ventilation |
86 | ″ | ″ | intervention |
87 | ″ | ″ | intervention arm |
88 | ″ | ″ | invasive ventilation |
89 | ″ | ″ | key elements |
90 | ″ | ″ | letter |
91 | ″ | ″ | levels |
92 | ″ | ″ | management |
93 | ″ | ″ | manual |
94 | ″ | ″ | materials |
95 | ″ | ″ | measurements |
96 | ″ | ″ | mechanical ventilation |
97 | ″ | ″ | method |
98 | ″ | ″ | min |
99 | ″ | ″ | modalities |
100 | ″ | ″ | moment |
101 | ″ | ″ | mortality benefit |
102 | ″ | ″ | nebulization |
103 | ″ | ″ | necessary sample size |
104 | ″ | ″ | non-inferiority design |
105 | ″ | ″ | non-invasive ventilation |
106 | ″ | ″ | non-specialized personnel |
107 | ″ | ″ | noninferiority |
108 | ″ | ″ | number |
109 | ″ | ″ | number 1 |
110 | ″ | ″ | order |
111 | ″ | ″ | oscillating device |
112 | ″ | ″ | outcome measurements |
113 | ″ | ″ | oxygenation level |
114 | ″ | ″ | participants |
115 | ″ | ″ | patients |
116 | ″ | ″ | personnel |
117 | ″ | ″ | physicians |
118 | ″ | ″ | physiotherapists |
119 | ″ | ″ | physiotherapy |
120 | ″ | ″ | pilot |
121 | ″ | ″ | positive pressure ventilation |
122 | ″ | ″ | potential staff shortages |
123 | ″ | ″ | power |
124 | ″ | ″ | pragmatic design |
125 | ″ | ″ | pressure ventilation |
126 | ″ | ″ | primary outcome measurement |
127 | ″ | ″ | procedure |
128 | ″ | ″ | protocol |
129 | ″ | ″ | random numbers |
130 | ″ | ″ | randomization |
131 | ″ | ″ | recruitment |
132 | ″ | ″ | related complications |
133 | ″ | ″ | research assistants |
134 | ″ | ″ | responsible physician |
135 | ″ | ″ | saline nebulization |
136 | ″ | ″ | sample size |
137 | ″ | ″ | samples |
138 | ″ | ″ | setting |
139 | ″ | ″ | shortage |
140 | ″ | ″ | signs |
141 | ″ | ″ | sites |
142 | ″ | ″ | situation |
143 | ″ | ″ | size |
144 | ″ | ″ | staff shortages |
145 | ″ | ″ | standard chest physiotherapy |
146 | ″ | ″ | start |
147 | ″ | ″ | stratification |
148 | ″ | ″ | structured summary |
149 | ″ | ″ | study |
150 | ″ | ″ | study protocol |
151 | ″ | ″ | study sites |
152 | ″ | ″ | summary |
153 | ″ | ″ | supportive management |
154 | ″ | ″ | tidal volume |
155 | ″ | ″ | treatment |
156 | ″ | ″ | trials |
157 | ″ | ″ | unexpected extubation |
158 | ″ | ″ | units |
159 | ″ | ″ | unnecessary exposure |
160 | ″ | ″ | ventilation |
161 | ″ | ″ | ventilator settings |
162 | ″ | ″ | virus |
163 | ″ | ″ | vital signs |
164 | ″ | ″ | volume |
165 | ″ | ″ | vomiting |
166 | ″ | ″ | websites |
167 | ″ | ″ | workers |
168 | ″ | schema:name | Comparison of two methods to clear the airways of critically ill children and adults with COVID-19 infection: a structured summary of a study protocol for a pilot randomized controlled trial |
169 | ″ | schema:pagination | 610 |
170 | ″ | schema:productId | N39d55048f5cf462f8ba8f208d67a46de |
171 | ″ | ″ | N3f648fb56ec44d2b810959998d3b87bf |
172 | ″ | ″ | N4c9f0f7c72264cf9b3756a8be7aea6d4 |
173 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1128973322 |
174 | ″ | ″ | https://doi.org/10.1186/s13063-020-04533-6 |
175 | ″ | schema:sdDatePublished | 2022-05-20T07:37 |
176 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
177 | ″ | schema:sdPublisher | N0ce48d041cde4df58f4a865446b03918 |
178 | ″ | schema:url | https://doi.org/10.1186/s13063-020-04533-6 |
179 | ″ | sgo:license | sg:explorer/license/ |
180 | ″ | sgo:sdDataset | articles |
181 | ″ | rdf:type | schema:ScholarlyArticle |
182 | N0ce48d041cde4df58f4a865446b03918 | schema:name | Springer Nature - SN SciGraph project |
183 | ″ | rdf:type | schema:Organization |
184 | N0dacabd4753841109f5269e05d8bddb3 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
185 | ″ | schema:name | Coronavirus Infections |
186 | ″ | rdf:type | schema:DefinedTerm |
187 | N0f59291a2e2e43058f0be6462f9453bd | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
188 | ″ | schema:name | COVID-19 |
189 | ″ | rdf:type | schema:DefinedTerm |
190 | N1a783f2138a0441c9cd6ce95b5bef71f | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
191 | ″ | schema:name | Pandemics |
192 | ″ | rdf:type | schema:DefinedTerm |
193 | N1e48c0212a754598b9da8c3a48591052 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
194 | ″ | schema:name | Lung |
195 | ″ | rdf:type | schema:DefinedTerm |
196 | N25669df7f7f24a1fb369f23bb2ffe916 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
197 | ″ | schema:name | Multicenter Studies as Topic |
198 | ″ | rdf:type | schema:DefinedTerm |
199 | N296db1fe4f844448a6706dcbec77b657 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
200 | ″ | schema:name | Equivalence Trials as Topic |
201 | ″ | rdf:type | schema:DefinedTerm |
202 | N2a035d0edf5c47f4b4ceecdab2110af8 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
203 | ″ | schema:name | Respiration, Artificial |
204 | ″ | rdf:type | schema:DefinedTerm |
205 | N39d55048f5cf462f8ba8f208d67a46de | schema:name | dimensions_id |
206 | ″ | schema:value | pub.1128973322 |
207 | ″ | rdf:type | schema:PropertyValue |
208 | N3b0fe888751c4ef3a2ef207eef389003 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
209 | ″ | schema:name | Pneumonia, Viral |
210 | ″ | rdf:type | schema:DefinedTerm |
211 | N3f648fb56ec44d2b810959998d3b87bf | schema:name | pubmed_id |
212 | ″ | schema:value | 32620174 |
213 | ″ | rdf:type | schema:PropertyValue |
214 | N48c17be93ea04bcab97e2d12a7f24e4b | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
215 | ″ | schema:name | Physical Therapy Modalities |
216 | ″ | rdf:type | schema:DefinedTerm |
217 | N4c9f0f7c72264cf9b3756a8be7aea6d4 | schema:name | doi |
218 | ″ | schema:value | 10.1186/s13063-020-04533-6 |
219 | ″ | rdf:type | schema:PropertyValue |
220 | N54bb9d8383a041598be4636ff52494ac | rdf:first | sg:person.0763066411.12 |
221 | ″ | rdf:rest | N64d260d5c3804a51b072fa1cbd603c6f |
222 | N5864f4d51276498f891988ca353457ba | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
223 | ″ | schema:name | SARS-CoV-2 |
224 | ″ | rdf:type | schema:DefinedTerm |
225 | N5a42fb85af6246aa89cd747d37615896 | rdf:first | sg:person.010332126163.53 |
226 | ″ | rdf:rest | N5baad2c14ed1493c8ef6799db4b3d681 |
227 | N5baad2c14ed1493c8ef6799db4b3d681 | rdf:first | sg:person.0701307445.10 |
228 | ″ | rdf:rest | Nc9ba71d910a6467f903b30ca238234ae |
229 | N644a191afa434ccfbac6926ef4f7c1c7 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
230 | ″ | schema:name | Quebec |
231 | ″ | rdf:type | schema:DefinedTerm |
232 | N64d260d5c3804a51b072fa1cbd603c6f | rdf:first | sg:person.01357623642.21 |
233 | ″ | rdf:rest | Na485ef5d2aa34fedabf3d7d628fcc46c |
234 | N69d2d850293840cbabd39ca452f4e254 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
235 | ″ | schema:name | Pilot Projects |
236 | ″ | rdf:type | schema:DefinedTerm |
237 | N74889e30e96d42cab7a33e8e1a079498 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
238 | ″ | schema:name | Host-Pathogen Interactions |
239 | ″ | rdf:type | schema:DefinedTerm |
240 | N80bbe4655b474abd8a77d70e43e9ae5c | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
241 | ″ | schema:name | Critical Illness |
242 | ″ | rdf:type | schema:DefinedTerm |
243 | N86d42ebd23b441f1a96ec4ff90919f4d | schema:issueNumber | 1 |
244 | ″ | rdf:type | schema:PublicationIssue |
245 | N99879bd0190546c092577b89858a4298 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
246 | ″ | schema:name | Humans |
247 | ″ | rdf:type | schema:DefinedTerm |
248 | N9c9fef50df9f4fe0a5a2431f5ae23032 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
249 | ″ | schema:name | Prospective Studies |
250 | ″ | rdf:type | schema:DefinedTerm |
251 | N9edaeb4626b842c785a5729f27d1a89c | rdf:first | sg:person.01254157220.25 |
252 | ″ | rdf:rest | rdf:nil |
253 | Na0c1fdf5ff0b4c7eadf357a7dea580ec | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
254 | ″ | schema:name | Betacoronavirus |
255 | ″ | rdf:type | schema:DefinedTerm |
256 | Na485ef5d2aa34fedabf3d7d628fcc46c | rdf:first | sg:person.01051400466.56 |
257 | ″ | rdf:rest | N9edaeb4626b842c785a5729f27d1a89c |
258 | Nc0fe7d8bf52f4ee4b2d9066b4d849109 | rdf:first | sg:person.0736602315.48 |
259 | ″ | rdf:rest | N5a42fb85af6246aa89cd747d37615896 |
260 | Nc9ba71d910a6467f903b30ca238234ae | rdf:first | Nef7b4c6f51314a83881584588a823e87 |
261 | ″ | rdf:rest | N54bb9d8383a041598be4636ff52494ac |
262 | Nd6b92a98f6af43ab8c4f5c1e685080e5 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
263 | ″ | schema:name | Time Factors |
264 | ″ | rdf:type | schema:DefinedTerm |
265 | Ne3d9e258e0754cddac2fec7a1da174f4 | schema:volumeNumber | 21 |
266 | ″ | rdf:type | schema:PublicationVolume |
267 | Neb6062775ddd4db4aba246b63c77244b | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
268 | ″ | schema:name | Treatment Outcome |
269 | ″ | rdf:type | schema:DefinedTerm |
270 | Nef7b4c6f51314a83881584588a823e87 | schema:affiliation | grid-institutes:grid.14848.31 |
271 | ″ | schema:familyName | El Salti |
272 | ″ | schema:givenName | Saly |
273 | ″ | rdf:type | schema:Person |
274 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
275 | ″ | schema:name | Medical and Health Sciences |
276 | ″ | rdf:type | schema:DefinedTerm |
277 | anzsrc-for:1103 | schema:inDefinedTermSet | anzsrc-for: |
278 | ″ | schema:name | Clinical Sciences |
279 | ″ | rdf:type | schema:DefinedTerm |
280 | sg:journal.1297400 | schema:issn | 1468-6708 |
281 | ″ | ″ | 1745-6215 |
282 | ″ | schema:name | Trials |
283 | ″ | schema:publisher | Springer Nature |
284 | ″ | rdf:type | schema:Periodical |
285 | sg:person.010332126163.53 | schema:affiliation | grid-institutes:grid.14848.31 |
286 | ″ | schema:familyName | Bernier |
287 | ″ | schema:givenName | Gabrielle |
288 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010332126163.53 |
289 | ″ | rdf:type | schema:Person |
290 | sg:person.01051400466.56 | schema:affiliation | grid-institutes:None |
291 | ″ | schema:familyName | Khwaja |
292 | ″ | schema:givenName | Kosar |
293 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051400466.56 |
294 | ″ | rdf:type | schema:Person |
295 | sg:person.01254157220.25 | schema:affiliation | grid-institutes:grid.14848.31 |
296 | ″ | schema:familyName | Jouvet |
297 | ″ | schema:givenName | Philippe |
298 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254157220.25 |
299 | ″ | rdf:type | schema:Person |
300 | sg:person.01357623642.21 | schema:affiliation | grid-institutes:grid.63984.30 |
301 | ″ | schema:familyName | Lee |
302 | ″ | schema:givenName | Todd C. |
303 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357623642.21 |
304 | ″ | rdf:type | schema:Person |
305 | sg:person.0701307445.10 | schema:affiliation | grid-institutes:grid.14848.31 |
306 | ″ | schema:familyName | Lacroix |
307 | ″ | schema:givenName | Jacques |
308 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701307445.10 |
309 | ″ | rdf:type | schema:Person |
310 | sg:person.0736602315.48 | schema:affiliation | grid-institutes:grid.414148.c |
311 | ″ | schema:familyName | Kawaguchi |
312 | ″ | schema:givenName | Atsushi |
313 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736602315.48 |
314 | ″ | rdf:type | schema:Person |
315 | sg:person.0763066411.12 | schema:affiliation | grid-institutes:None |
316 | ″ | schema:familyName | Cheng |
317 | ″ | schema:givenName | Matthew P. |
318 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763066411.12 |
319 | ″ | rdf:type | schema:Person |
320 | grid-institutes:None | schema:alternateName | McGill Interdisciplinary Initiative in Infection and Immunity, Quebec, Canada |
321 | ″ | ″ | Réseau de Recherche en Santé Respiratoire du Québec, Quebec, Canada |
322 | ″ | schema:name | Divisions of Infectious Diseases and Medical Microbiology, McGill University Health Centre, Quebec, Canada |
323 | ″ | ″ | McGill Interdisciplinary Initiative in Infection and Immunity, Quebec, Canada |
324 | ″ | ″ | Réseau de Recherche en Santé Respiratoire du Québec, Quebec, Canada |
325 | ″ | rdf:type | schema:Organization |
326 | grid-institutes:grid.14848.31 | schema:alternateName | Department of Pediatrics, University of Montreal, CHU Sainte-Justine, 3175 Chemin de Côte Sainte Catherine, H3T 1C5, Quebec, QB, Canada |
327 | ″ | ″ | School of Medicine, University of Montreal, Quebec, Canada |
328 | ″ | schema:name | Department of Pediatrics, University of Montreal, CHU Sainte-Justine, 3175 Chemin de Côte Sainte Catherine, H3T 1C5, Quebec, QB, Canada |
329 | ″ | ″ | School of Medicine, University of Montreal, Quebec, Canada |
330 | ″ | rdf:type | schema:Organization |
331 | grid-institutes:grid.414148.c | schema:alternateName | Department of Pediatrics, Children’s Hospital Eastern Ontario, University of Ottawa, Ottawa, Canada |
332 | ″ | schema:name | Department of Pediatrics, Children’s Hospital Eastern Ontario, University of Ottawa, Ottawa, Canada |
333 | ″ | ″ | Department of Pediatrics, University of Montreal, CHU Sainte-Justine, 3175 Chemin de Côte Sainte Catherine, H3T 1C5, Quebec, QB, Canada |
334 | ″ | rdf:type | schema:Organization |
335 | grid-institutes:grid.63984.30 | schema:alternateName | Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Quebec, Canada |
336 | ″ | schema:name | Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Quebec, Canada |
337 | ″ | ″ | McGill Interdisciplinary Initiative in Infection and Immunity, Quebec, Canada |
338 | ″ | rdf:type | schema:Organization |